SARS-CoV-2 Nucleocapsid Proteins

Sasisekharan, Pentakota, Jayaraman, Tharakaraman, Wogan, Narayanasami: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).

Dogan, Kozhaya, Placek, Gunter, Yigit, Hardy, Plassmeyer, Coatney, Lillard, Bukhari, Kleinberg, Hayes, Arditi, Klapper, Merin, Liang, Gupta, Alpan, Unutmaz: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." in: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).

Supekar, Shajahan, Gleinich, Rouhani, Heiss, Chapla, Moremen, Azadi: "Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein." in: Glycobiology, (2021) (PubMed).

Qian, Lei, Patel, Lee, Monaghan-Nichols, Xin, Qiu, Fu: "Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin." in: bioRxiv : the preprint server for biology, (2021) (PubMed).

Longworth, Dittmar: "An antigen microarray protocol for COVID-19 serological analysis." in: STAR protocols, Vol. 2, Issue 3, pp. 100815, (2021) (PubMed).

Johnson, Drugan, Miller, Evans: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)

Rudberg, Havervall, Månberg, Jernbom Falk, Aguilera, Ng, Gabrielsson, Salomonsson, Hanke, Murrell, McInerney, Olofsson, Andersson, Hellström, Bayati, Bergström, Pin, Sjöberg, Tegel, Hedhammar et al.: "SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. ..." in: Nature communications, Vol. 11, Issue 1, pp. 5064, (2020) (PubMed).